MedTrace Logo

Endothelial Dysfunction in Subjects With History of Premature Coronary Artery Disease

NCT00917527 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2012-07-23

No results posted yet for this study

Summary

The aim of this prospective study is to investigate the prevalence of endothelial dysfunction in subjects with family history of premature coronary heart disease. At the same time, the effect of atorvastatin in treating subclinical endothelial dysfunction in those patients will be evaluated.

Conditions

Interventions

DRUG

Atorvastatin

Atorvastatin 40mg/D for 6 weeks to improve endothelial dysfunction

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • Hyuk-Jae Chang, MD, PhD · Cardiology Division, Severance Cardiovascular Hospital, Yonsei University College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2012-11-30
Completion
2013-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00917527 on ClinicalTrials.gov